ArticleSN comprehensive clinical medicine2022

COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint Inhibitors.

Mengni Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.